RenovoRx Inc

RenovoRx Inc

RNXT

Get informed when a big investor buys or sells

+ Follow
Market Cap$33.85M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
RenovoRx IncRenovoRx Inc-2.8--109%--
$0.37

Current Fair Value

59.4% downside

Overvalued by 59.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$33.85 Million
Enterprise Value$21.57 Million
Dividend Yield$- (-)
Earnings per Share$-0.32
Beta1
Outstanding Shares38,032,421

Return

Return on Equity-108.91%ROE
Return on Assets-87.86%
Return on Invested Capital-106.85%

Valuation & Multiples

P/E Ratio-2.82P/E Ratio
PEG-6.2PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue14.49
Enterprise Value to EBIT-1.68
Enterprise Value to Net Income-2
Total Debt to Enterprise0
Debt to Equity0.01Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 21, 2026
EPS Estimate
$-0.08
Average shareholder expectation
Revenue Estimate
$469,500
Average shareholder expectation

Next Earnings Call

Expected Date
August 13, 2026
EPS Estimate
$-0.08
Average shareholder expectation
Revenue Estimate
$703,750
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %24.24% 6.30%
Total Invested$8.58M 25.68%
Investors Holding31 2.00%

ESG Score

No data

About RenovoRx Inc

2,021 employees